Kuttesch J - Search Results

1

Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.

Pappo AS, Crist WM, Kuttesch J, Rowe S, Ashmun RA, Maurer HM, Newton WA, Asmar L, Luo X, Shapiro DN. Pappo AS, et al. Among authors: kuttesch j. J Clin Oncol. 1993 Oct;11(10):1901-5. doi: 10.1200/JCO.1993.11.10.1901. J Clin Oncol. 1993. PMID: 8410116

2

P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma.

Kuttesch JF, Parham DM, Luo X, Meyer WH, Bowman L, Shapiro DN, Pappo AS, Crist WM, Beck WT, Houghton PJ. Kuttesch JF, et al. J Clin Oncol. 1996 Mar;14(3):886-900. doi: 10.1200/JCO.1996.14.3.886. J Clin Oncol. 1996. PMID: 8622037

3

Malignant melanocytic lesions of unknown primary site in children and adolescents.

Pappo AS, Kuttesch JF, Kaste SC, Parham DM, Rao BN, Pratt CB. Pappo AS, et al. Among authors: kuttesch jf. Med Pediatr Oncol. 1995 May;24(5):315-20. doi: 10.1002/mpo.2950240509. Med Pediatr Oncol. 1995. PMID: 7700184

4

Phase I study of topotecan for pediatric patients with malignant solid tumors.

Pratt CB, Stewart C, Santana VM, Bowman L, Furman W, Ochs J, Marina N, Kuttesch JF, Heideman R, Sandlund JT, et al. Pratt CB, et al. Among authors: kuttesch jf. J Clin Oncol. 1994 Mar;12(3):539-43. doi: 10.1200/JCO.1994.12.3.539. J Clin Oncol. 1994. PMID: 8120551 Clinical Trial.

5

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas.

Heideman RL, Douglass EC, Krance RA, Fontanesi J, Langston JA, Sanford RA, Kovnar EH, Ochs J, Kuttesch J, Jenkins JJ, et al. Heideman RL, et al. Among authors: kuttesch j. J Clin Oncol. 1993 Aug;11(8):1458-65. doi: 10.1200/JCO.1993.11.8.1458. J Clin Oncol. 1993. PMID: 8336185

6

Phase I study of combination topotecan and carboplatin in pediatric solid tumors.

Athale UH, Stewart C, Kuttesch JF, Moghrabi A, Meyer W, Pratt C, Gajjar A, Heideman RL. Athale UH, et al. J Clin Oncol. 2002 Jan 1;20(1):88-95. doi: 10.1200/JCO.2002.20.1.88. J Clin Oncol. 2002. PMID: 11773158 Clinical Trial.

7

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.

Kuttesch JF Jr, Wexler LH, Marcus RB, Fairclough D, Weaver-McClure L, White M, Mao L, Delaney TF, Pratt CB, Horowitz ME, Kun LE. Kuttesch JF Jr, et al. J Clin Oncol. 1996 Oct;14(10):2818-25. doi: 10.1200/JCO.1996.14.10.2818. J Clin Oncol. 1996. PMID: 8874344

8

Embryonal malignancies of unknown primary origin in children.

Kuttesch JF Jr, Parham DM, Kaste SC, Rao BN, Douglass EC, Pratt CB. Kuttesch JF Jr, et al. Cancer. 1995 Jan 1;75(1):115-21. doi: 10.1002/1097-0142(19950101)75:1<115::aid-cncr2820750119>3.0.co;2-0. Cancer. 1995. PMID: 7804965

9

Supratentorial malignant gliomas in childhood: a single institution perspective.

Heideman RL, Kuttesch J Jr, Gajjar AJ, Walter AW, Jenkins JJ, Li Y, Sanford RA, Kun LE. Heideman RL, et al. Among authors: kuttesch j jr. Cancer. 1997 Aug 1;80(3):497-504. doi: 10.1002/(sici)1097-0142(19970801)80:3<497::aid-cncr18>3.0.co;2-s. Cancer. 1997. PMID: 9241084

10

Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.

Chintagumpala M, Blaney SM, Bomgaars LR, Aleksic A, Kuttesch JF, Klenke RA, Berg SL. Chintagumpala M, et al. J Clin Oncol. 2004 Nov 1;22(21):4394-400. doi: 10.1200/JCO.2004.04.565. J Clin Oncol. 2004. PMID: 15514381 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page